New pill aims to stop dangerous blood pressure drops in rare brain disease
Symptom relief
Ongoing
This phase 3 study tests a drug called ampreloxetine for people with multiple system atrophy (MSA) who experience dizziness and fainting due to low blood pressure when standing. About 102 adults with MSA will take the drug for 20 weeks, then some will switch to placebo to see if …
Phase: PHASE3 • Sponsor: Theravance Biopharma • Aim: Symptom relief
Last updated Jun 26, 2026 13:24 UTC